GEHC 财务： GE Healthcare Technologies Inc AI 分析

Q: GE Healthcare Technologies Inc 的关键财务报表是什么？

根据最新的财务报表（Form-10K），GE Healthcare Technologies Inc 的总资产为 $33,089，净利润为 $1,993

Q: GEHC 的关键财务比率是什么？

GE Healthcare Technologies Inc 的流动比率是 1.34，净利 margin 为 10.13，每股销售为 $42.85。

Q: GE Healthcare Technologies Inc 的收入按细分市场或地理位置如何划分？

GE Healthcare Technologies Inc 最大收入来源是 Product，在最近的收益报告中收入为 13,075,000,000。就地区而言， USCAN 是 GE Healthcare Technologies Inc 的主要市场，收入为 8,981,000,000。

Q: GE Healthcare Technologies Inc 是否盈利？

是的，根据最新的财务报表，GE Healthcare Technologies Inc 的净利润为 $1,993

Q: GE Healthcare Technologies Inc 有负债吗？

是的，GE Healthcare Technologies Inc 的负债为 24,643

Q: GE Healthcare Technologies Inc 的流通股有多少？

GE Healthcare Technologies Inc 的总流通股为 456.95

主页

股票

GEHC

GEHC 财务

GE Healthcare Technologies Inc

$78.83

-3.57%

$-2.92

收盘价：Jan 20, 16:00:00 GMT-5

$79

0.21%

$0.17

盘后：Jan 20, 20:00:00 GMT-5

概述预测收益股息财务数据

360

报告

B-

最终得分

关键数据

前收盘价

$81.75

开盘价

$79.68

当日区间

$78.31 - $80

52周范围

$57.65 - $94.8

交易量

5.4M

平均成交量

3.4M

每股收益（TTM）

4.84

股息收益率

0.16%

市值

$35.9B

什么是 GEHC？

GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 53,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

功能特性

交易策略

资源

市场

收入

资产负债表

现金流量

年度

季度性

GEHC 收入

以百万美元为单位的财务数据。财年为2月至次年1月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
营收	20,246	19,672	19,552	18,341	17,585	17,164
营收同比增长 (YoY)	4%	1%	7%	4%	2%	3%
营收成本	11,986	11,467	11,630	11,162	10,411	10,397
毛利润	8,260	8,205	7,922	7,179	7,174	6,767
销售、一般及管理费用	4,244	4,269	4,282	3,631	3,563	3,237
研发	1,282	1,311	1,205	1,026	816	810
营业费用	5,523	5,580	5,487	4,657	4,379	4,047
其他非经营性收入 (费用)	369	453	431	63	181	112
税前利润	2,782	2,581	2,361	2,512	2,875	2,710
所得税费用	492	531	743	563	600	652
净利润	2,217	1,993	1,385	1,916	2,247	13,846
净利润增长	32%	44%	-28%	-15%	-84%	809%
稀释后流通股数	457	459	458	453.92	454.71	454.71
股份同比变动 (YoY)	0%	0%	1%	0%	0%	0%
每股收益 (摊薄)	4.83	4.34	3.03	4.22	4.94	30.45
每股收益增长率	32%	43%	-28%	-15%	-84%	809%
自由现金流	1,400	1,550	1,714	1,803	1,359	2,359
每股自由现金流	--	--	--	--	--	--
毛利率	40.79%	41.7%	40.51%	39.14%	40.79%	39.42%
营业利润率	13.51%	13.34%	12.45%	13.75%	15.89%	15.84%
净利率	10.95%	10.13%	7.08%	10.44%	12.77%	80.66%
自由现金流利润率	6.91%	7.87%	8.76%	9.83%	7.72%	13.74%
EBITDA	3,309	3,205	3,045	3,155	3,420	3,350
EBITDA 利润率	16.34%	16.29%	15.57%	17.2%	19.44%	19.51%
EBITDA 中的折旧与摊销	572	580	610	633	625	630
EBIT	2,737	2,625	2,435	2,522	2,795	2,720
EBIT 利润率	13.51%	13.34%	12.45%	13.75%	15.89%	15.84%
有效税率	17.68%	20.57%	31.46%	22.41%	20.86%	24.05%

Follow-Up Questions

GE Healthcare Technologies Inc 的关键财务报表是什么？



GEHC 的关键财务比率是什么？



GE Healthcare Technologies Inc 的收入按细分市场或地理位置如何划分？



GE Healthcare Technologies Inc 是否盈利？



GE Healthcare Technologies Inc 有负债吗？



GE Healthcare Technologies Inc 的流通股有多少？



GE Healthcare Technologies Inc（GEHC）价格

GEHC 股价走势图